The Silicon Review - Best Business Review Magazine 50 Most Trustworthy Companies 2019 | Page 22

Unlocking the Power of the
Genome - Illumina
A
s a global company that
places a high value on
collaborative interactions,
rapid delivery of solutions, and
providing the highest level of
quality, Illumina strives to meet this
challenge.
Illumina innovative sequencing
and array technologies are fueling
groundbreaking advancements in
life science research, translational
and consumer genomics, and
molecular diagnostics. Sequencing
and array-based solutions for the
analysis of genetic variation and
function, in fields ranging from
cancer research to agriculture
Driving Innovation
As a startup, Illumina aspired to
transform human health. Its initial
products enabled researchers to
explore DNA at an entirely new
Francis deSouza
President & CEO
scale, helping them create the first
map of gene variations associated
with health, disease, and drug
response. Every breakthrough
opened up a new world and showed
it how much further there is to go.
Finding Answers
While the rate of progress is
accelerating exponentially, it is only
beginning to understand the clinical
significance of the genome. What
causes a cancer cell to mutate? What
is the origin of a puzzling disease?
Is it possible to prevent the next
outbreak? Or safeguard the world’s
food supply? These are just a few of
the challenges that inspire it to push
the boundaries of its imagination.
Making a Difference Now
Today Illumina is a global leader
in genomics – an industry at
the intersection of biology and
technology. At the most fundamental
level, it enables its customers
to read and understand genetic
variations. The firm strives to make
its solutions increasingly simple,
more accessible, and always reliable.
As a result, discoveries that were
unimaginable even a few years ago
are now becoming routine – and
are making their way into patient
treatment.
Empowering a Healthy
Future
Illumina now can sequence on an
unprecedented scale. Collectively,
this will give it a much deeper
understanding of genetics than ever
before. The company will begin
to truly unlock the power of the
genome. These advances will trigger
a fundamental shift in healthcare
“Our goal is to apply innovative
technologies to the analysis of genetic
variation and function, making
studies possible that were not even
imaginable just a few years ago. It
is mission-critical for us to deliver
innovative, flexible, and scalable
solutions to meet the needs of our
customers.”